Pangenomic Health Inc.
NARA
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 51.17% | -346.08% | -2.79% | 53.78% | -316.77% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | -93.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.30% | 25,022.22% | -97.95% | 24.79% | 198.72% |
| Change in Net Operating Assets | 154.84% | -239.81% | 5.20% | -68.50% | 290.85% |
| Cash from Operations | 85.70% | -824.39% | -282.72% | -41.98% | -287.61% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | 241.12% | -100.00% | -- | -- | -- |
| Issuance of Common Stock | -99.64% | 1,775.40% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -198.33% | 111.93% | -213.54% | 2,505.88% | -- |
| Cash from Financing | -89.19% | 849.15% | 281.88% | 2,475.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -156.55% | 1,864.29% | 250.00% | 104.00% | -276.99% |